Publications

Explore the Impact of Aster Insights

Learn how Aster Insights is advancing the fight against cancer by driving precision oncology and drug discovery.

15+

Years of Data & Insights

100+

Publications

400,000

TCC^® Patients

ORIEN^® Members

Filters

Research Focus

Biomarkers
Cancer Disparities
Cancer Prevention
Clinical Trial
Drug Resistance
Gene Signatures
Immuno-oncology
Molecular Genetics/ Genomics
Radiation Oncology
Tumor Microbiome
Tumor Microenvironment

Cancer Type

Breast
Gastrointestinal
Genitourinary
Gynecologic
Head and Neck
Hematologic
Lung
Pan-cancer
Sarcoma
Skin

Data Utilized

ORIEN Avatar (multi-institution)
ORIEN Avatar (single institution)
Total Cancer Care

ORDER BY

All Publications

Transcriptome-Wide Association Study Among 97,898 Women to Identify Candidate Susceptibility Genes for Epithelial Ovarian Cancer Risk. Lu Y, Beeghly-Fadiel A, Wu L, et al.

2018

Circulating T Cell Subpopulations Correlate With Immune Responses at the Tumor Site and Clinical Response to PD1 Inhibition in Non-Small Cell Lung Cancer. Manjarrez-Orduño N, Menard LC, Kansal S, et al.

2018

Patient Enrichment for Precision-Based Cancer Clinical Trials: Using Prospective Cohort Surveillance as an Approach to Improve Clinical Trials. Dalton,WS, Sullivan D, Ecsedy J, et al.

2018

Subsequent primary malignancies among multiple myeloma patients treated with or without lenalidomide. Rollison, D. E., Komrokji, R., Lee, J. H., et al.

2017

Relative protein quantification and accessible biology in lung tumor proteomes from four LC-MS/MS discovery platforms. Stewart PA, Fang B, Slebos RJ, et al.

2017

Improved local and regional control with radiotherapy for Merkel cell carcinoma of the head and neck. Strom T, Naghavi AO, Messina JL, et al.

2017

An Ex Vivo Platform for the Prediction of Clinical Response in Multiple Myeloma. Silva A, Silva MC, Sudalagunta P, et al.

2017

Use of the Total Cancer Care System to Enrich Screening for CD30-Positive Solid Tumors for Patient Enrollment Into a Brentuximab Vedotin Clinical Trial: A Pilot Study to Evaluate Feasibility. Li B, Eschrich SA, Berglund A, Mitchell M, et al.

2017

Evaluation of invasive breast cancer samples using a 12-chemokine gene expression score: correlation with clinical outcomes. Prabhakaran S, Rizk VT, Ma Z, et al.

2017

Unification of de novo and acquired ibrutinib resistance in mantle cell lymphoma. Zhao X, Lwin T, Silva A, et al.

2017

Pages: 1234567891011

Whitepapers

Aster Insights and ORIEN^® have published hundreds of papers in dozens of scientific journals based on Total Cancer Care^® and Aster Insights data.

Chart A Samples line graph, Chart B table data, Chart C Samples bar graph CRC white paper

Consensus Molecular Subtype Analyses in Colorectal Cancer Samples

April 2023
Authors: David M. McKean, PhD, Daniel Elgort, PhD, Oliver A. Hampton, PhD, MS, Phaedra Agius, PhD

Figure 2 3 charts within RCC White Paper chart OS by Risk Group, Stages

Independent confirmation of the prognostic significance of an immune-related signature in clear cell renal cell carcinoma utilizing real world clinicogenomic data

April 2023
Authors: Michael Radmacher, PhD, Daniel Elgort, PhD, Oliver A. Hampton, PhD, MS, and Phaedra Agius, PhD